Annual Short Term Debt
$6.25 M
-$20.67 M-76.78%
31 December 2022
Summary:
Eagle Pharmaceuticals annual short term debt is currently $6.25 million, with the most recent change of -$20.67 million (-76.78%) on 31 December 2022. During the last 3 years, it has fallen by -$2.87 million (-31.49%). EGRX annual short term debt is now -76.78% below its all-time high of $26.92 million, reached on 31 December 2021.EGRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$9.72 M
+$632.00 K+6.95%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly short term debt is currently $9.72 million, with the most recent change of +$632.00 thousand (+6.95%) on 30 June 2023. EGRX quarterly short term debt is now -91.71% below its all-time high of $117.27 million, reached on 31 March 2020.EGRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -31.5% | +5.7% |
| 5 y5 years | 0.0% | +91.2% |
EGRX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.8% | at low | -73.3% | +24.9% |
| 5 y | 5 years | -76.8% | +25.0% | -91.7% | +94.4% |
| alltime | all time | -76.8% | +28.2% | -91.7% |
Eagle Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $9.72 M(+7.0%) |
| Mar 2023 | - | $9.09 M(+16.7%) |
| Dec 2022 | $6.25 M(-76.8%) | $7.78 M(-78.7%) |
| Sept 2022 | - | $36.47 M(+56.4%) |
| June 2022 | - | $23.32 M(-7.0%) |
| Mar 2022 | - | $25.06 M(-6.9%) |
| Dec 2021 | $26.92 M(+195.0%) | $26.92 M(+192.6%) |
| Sept 2021 | - | $9.20 M(+0.3%) |
| June 2021 | - | $9.17 M(+0.3%) |
| Mar 2021 | - | $9.15 M(+0.3%) |
| Dec 2020 | $9.12 M | $9.12 M(+0.1%) |
| Sept 2020 | - | $9.12 M(+12.4%) |
| June 2020 | - | $8.11 M(-93.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $117.27 M(+2245.3%) |
| Dec 2019 | $5.00 M(-20.0%) | $5.00 M(-1.7%) |
| Sept 2019 | - | $5.08 M(-16.0%) |
| June 2019 | - | $6.05 M(+21.0%) |
| Mar 2019 | - | $5.00 M(-20.0%) |
| Dec 2018 | $6.25 M(+28.2%) | $6.25 M(+25.0%) |
| Sept 2018 | - | $5.00 M(-20.0%) |
| June 2018 | - | $6.25 M(0.0%) |
| Mar 2018 | - | $6.25 M(+28.2%) |
| Dec 2017 | $4.88 M(-43.1%) | $4.88 M(-2.5%) |
| Sept 2017 | - | $5.00 M(>+9900.0%) |
| Dec 2013 | - | $0.00 |
| Sept 2012 | $8.57 M | - |
FAQ
- What is Eagle Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual short term debt?
The current annual short term debt of EGRX is $6.25 M
What is the all time high annual short term debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual short term debt is $26.92 M
What is Eagle Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of EGRX is $9.72 M
What is the all time high quarterly short term debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly short term debt is $117.27 M